As of 2026-05-23, the EV/EBITDA ratio of Hua Medicine (2552.HK) is 2.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 2552.HK's latest enterprise value is 2,533.26 mil HKD. 2552.HK's TTM EBITDA according to its financial statements is 1,144.89 mil HKD. Dividing these 2 quantities gives us the above 2552.HK EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 19.7x | 18.9x |
| Forward P/E multiples | 8.2x - 9.1x | 8.9x |
| Fair Price | 12.40 - 25.52 | 18.96 |
| Upside | 280.4% - 682.7% | 481.5% |
| Date | EV/EBITDA |
| 2026-05-22 | 19.76 |
| 2026-05-21 | 19.89 |
| 2026-05-20 | 20.33 |
| 2026-05-19 | 20.64 |
| 2026-05-18 | 21.39 |
| 2026-05-15 | 22.27 |
| 2026-05-14 | 21.02 |
| 2026-05-13 | 21.52 |
| 2026-05-12 | 22.02 |
| 2026-05-11 | 20.89 |
| 2026-05-08 | 20.33 |
| 2026-05-07 | 20.45 |
| 2026-05-06 | 19.76 |
| 2026-05-05 | 20.45 |
| 2026-05-04 | 20.45 |
| 2026-04-30 | 20.33 |
| 2026-04-29 | 20.51 |
| 2026-04-28 | 20.26 |
| 2026-04-27 | 20.58 |
| 2026-04-24 | 20.89 |
| 2026-04-23 | 21.45 |
| 2026-04-22 | 21.77 |
| 2026-04-21 | 22.08 |
| 2026-04-20 | 22.27 |
| 2026-04-17 | 22.83 |
| 2026-04-16 | 23.34 |
| 2026-04-15 | 23.46 |
| 2026-04-14 | 23.40 |
| 2026-04-13 | 21.89 |
| 2026-04-10 | 22.27 |
| 2026-04-09 | 21.77 |
| 2026-04-08 | 22.21 |
| 2026-04-02 | 22.21 |
| 2026-04-01 | 22.27 |
| 2026-03-31 | 20.70 |
| 2026-03-30 | 21.45 |
| 2026-03-27 | 20.76 |
| 2026-03-26 | 18.82 |
| 2026-03-25 | 18.51 |
| 2026-03-24 | 18.44 |
| 2026-03-23 | 17.88 |
| 2026-03-20 | 18.76 |
| 2026-03-19 | 18.69 |
| 2026-03-18 | 19.51 |
| 2026-03-17 | 19.45 |
| 2026-03-16 | 19.57 |
| 2026-03-13 | 19.70 |
| 2026-03-12 | 19.38 |
| 2026-03-11 | 19.70 |
| 2026-03-10 | 20.26 |